Why hospital chains buying in Tier II & III cities

India's private healthcare sector is in the middle of a consolidation wave, and industry watchers say it's far from over. Hospital chains that once expanded by building new facilities from scratch are increasingly choosing to acquire existing hospitals instead, a shift that's reshaping where and how the country's next wave of medical infrastructure gets built.A decade in the making
The roots of this trend go back roughly ten years, according to Anant Kharad, Director at Anand Rathi Investment Banking. During that period, many healthcare providers took in large amounts of private equity and growth capital, often in the range of $20-40 million per deal. That funding helped hospitals scale up, and now many of these companies, both listed and unlisted, are hunting for their next phase of growth.

Rather than pursuing greenfield projects, building new hospitals from the ground up, many players are opting to acquire hospitals that are already up and running. The logic is straightforward: a functioning hospital already has an established patient base, a working relationship with local doctors, and a proven catchment area. Building all of that from zero takes years and significant local buy-in.Beyond the metros
While cities like Hyderabad, Bengaluru, Chennai, and Coimbatore already have strong bed capacity, and Kerala and Goa are similarly well-served, much of the rest of the country tells a different story. Roughly 22% of India's private hospital bed capacity is concentrated in just six metro cities, leaving the remaining 78% of the population served by comparatively limited infrastructure.

The most under-served regions, Kharad notes, fall within India's Hindi belt, Uttar Pradesh, Bihar, West Bengal, and Chhattisgarh. It's not a demand problem; patients in these regions can and do pay for quality care. The real bottleneck is simply a shortage of available beds. Major chains are taking notice: Max Healthcare has announced a 700-bed hospital in Lucknow, while Aster is investing in expansion projects of similar scale in the region.
ET logoLive Events
Not all deals are created equal
With bed capacity still below optimal levels nationally, India averages seven to eight beds per 10,000 people, compared to Goa's roughly 50, there's clear room for growth. Private players are expected to add around 35,000 new beds over the next five years.

But growth through acquisition isn't automatically profitable. Overpaying for facilities at inflated multiples can turn a promising deal into a value-destructive one. According to Kharad, the smarter strategy lies in how companies assess catchment areas, players with a strong presence in the north, for instance, may find more opportunity expanding into under-penetrated eastern or central India rather than competing in the already-saturated south, where most M&A activity has traditionally concentrated.What's next for hospital M&A
Looking ahead, Kharad expects a blended approach: some companies will lean into greenfield projects in select cities, while acquisitions will continue driving expansion elsewhere. Buying an established facility can be immediately EBITDA-accretive, avoiding the two-to-three-year runway typically needed to break even on a new hospital.

Crucially, Kharad doesn't see the pace of consolidation slowing down. As demand in metro and tier I cities stabilizes, tier II and tier III cities are emerging as the next major growth frontier — driven by rising rates of non-communicable diseases and a steadily aging population. With paying capacity already present in these regions, the primary constraint isn't affordability, it's simply getting enough quality beds built or bought. Industry analysts expect this theme to continue shaping healthcare investment in India for at least the next decade.


Add ET Logo as a Reliable and Trusted News Source
(You can now subscribe to our ETMarkets WhatsApp channel)
AI Article